SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $82.04 | 52-week high | $105.47 |
Prev. close | $82.38 | 52-week low | $66.66 |
Day low | $80.90 | Volume | 7,979,917 |
Day high | $82.84 | Avg. volume | 10,813,620 |
50-day MA | $80.02 | Dividend yield | 0.17% |
200-day MA | $89.90 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Biotech |
Assets Under Management (AUM) | 4.73M |
Net Asset Value (NAV) | $82.43 |
Options? | Yes |
Total Holdings | 130 |
XBI Top Holdings
Symbol | Company | % of Total |
ALNY | ALNYLAM PHARMACEUTICALS INC | 3.27% |
NTRA | NATERA INC | 3% |
BPMC | BLUEPRINT MEDICINES CORP | 2.99% |
NBIX | NEUROCRINE BIOSCIENCES INC | 2.96% |
EXK | EXACT SCIENCES CORP | 2.87% |
BRKR | INCYTE CORP | 2.56% |
GILD | GILEAD SCIENCES INC | 2.41% |
AMGN | AMGEN INC | 2.35% |
XBI Price Returns
1-mo | 3.80% |
3-mo | -5.79% |
6-mo | N/A |
1-year | -11.06% |
3-year | 6.64% |
5-year | -26.08% |
YTD | -8.90% |
2024 | 1.01% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |